So for MRKs new BTD, how is this going to work? the FDA approves their drug only for those indications 4 months before it goes it for all GT1?
Regarding MRK's strategy for pricing etc, any thoughts on what they plan on doing? I can't see them going after price so seems like they'd be more going after GILDs share, no? Any other thoughts?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.